The Business of Innovation
Ahead of the Ophthalmology Innovation Summit 2019 at AAO, we reach out to a panel of experts to uncover market trends – as well as the latest advances shaping the field
By bringing together clinical, capital and corporate leaders – all key stakeholders in the development and commercialization of novel technologies and therapies – the Ophthalmology Innovation Summit (OIS) has a clear objective: to act as an innovation accelerant, helping convert conceptual sparks into glowing success.
The brainchild of ophthalmologist and venture capitalist Emmett Cunningham (Blackstone Life Sciences) and experienced conference producer Craig Simak, OIS fully sprang into life when two fellow venture capitalists – William Link of Versant Ventures/Flying L Partners and ophthalmologist Gil Kliman of InterWest Partners – came on board to co-chair the initial programs. OIS had found a recipe for success.
The flagship “OIS@AAO” began in 2009 and – a decade on – will attract 1,200 leaders in ophthalmology with the common goal of addressing unmet vision needs. For 2019, the full-day (6:45 am–6:30 pm) program on October 10 covers everything from the game-changing technologies of today and tomorrow, to opportunities and challenges for healthcare leaders, to markets updates – not to mention a “Keynote Conversation” between Alex Gorsky, Chairman & CEO of Johnson & Johnson, and summit co-chair Link.
Here, we ask seasoned OIS experts to get us up to speed for OIS@AAO with notable approvals, business trends, and a glimpse of how the innovators of the future are being forged.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.